• PDF / 169,021 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 99 Downloads / 187 Views

DOWNLOAD

REPORT

---

1 S

Toxic hepatitis and pulmonary embolism: 2 case reports In an observational, retrospective, descriptive study of 58 patients with arthritis rheumatoid treated until January 2019, 2 patients including a 70-year-old patient [sexes not stated; not all ages stated] were described, who developed toxic hepatitis (1 patient) or pulmonary thromboembolism (a 70-year-old patient) during treatment with baricitinib and tofacitinib, respectively, for arthritis rheumatoid [dosages, routes, durations of treatments to reactions onsets and outcomes not stated]. The 70-year-old patient’s concurrent condition was reported to be hypertension. Velloso Feijoo ML, et al. Safety of JAK inhibitors in patients with arthritis rheumatoid under real-life conditions. Annals of the Rheumatic Diseases 79 (Suppl. 1): 1482 abstr. 803516319 AB0363, Jun 2020. Available from: URL: https://ard.bmj.com/content/79/Suppl_1/1482.2 [abstract]

0114-9954/20/1831-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 21 Nov 2020 No. 1831